EDWARDS LIFESCIENCES CORPORATION EW Income Statement

Edwards lifesciences corporation (EW)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Sep'09	Jun'09
Net sales
4,483	4,348	4,151	3,964	3,821	3,722	3,633	3,548	3,446	3,435	3,314	3,232	3,149	2,963	2,867	2,743	2,600	2,493	2,440	2,432	2,390	2,322	2,240	2,129	2,071	2,045	2,020	1,972	1,937	1,899	1,819	1,784	1,733	1,678	1,640	1,577	1,511	1,447	1,380	1,366	0	0	0
Cost of Goods and Services Sold
1,147	1,114	1,062	995	937	939	940	928	893	875	853	841	832	797	760	705	661	617	601	623	615	625	609	569	541	516	495	478	484	491	488	502	500	489	483	453	426	408	393	399	0	0	0
Gross profit
3,336	3,233	3,088	2,968	2,883	2,783	2,693	2,620	2,553	2,560	2,461	2,391	2,317	2,166	2,107	2,037	1,939	1,876	1,838	1,809	1,775	1,697	1,631	1,560	1,529	1,528	1,525	1,493	1,452	1,408	1,330	1,281	1,233	1,188	1,157	1,123	1,084	1,038	987	967	0	0	0
Selling, General and Administrative Expense
1,269	1,242	1,183	1,146	1,112	1,088	1,073	1,048	1,017	990	951	936	921	904	893	875	860	850	851	861	863	858	821	777	748	733	716	706	702	697	690	688	669	642	621	588	566	550	533	529	0	0	0
Research and development expenses
768	752	721	688	650	622	605	586	567	552	520	491	469	442	425	413	398	382	368	355	347	346	341	337	329	323	319	309	302	291	277	265	255	246	241	232	218	204	193	183	0	0	0
Intellectual property litigation expenses
41	33	214	214	212	214	-85	-80	-77	-73	36	29	30	32	31	27	18	7	-1,477	-1,481	-734	-740	734	730	-22	61	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability
-15	-6	-1	-5	-2	-5	10	0	-7	-9	-12	4	1	1	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Nonrecurring (Income) Expense
40	64	0	140	0	-	-	-21	9	9	31	65	0	-	0	0	-	-	0	0	-	70	0	0	0	-	-	-	-	-	-	0	-	-	-	0	-	-	0	0	-	0	0
Special charges (Note 4)
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other operating expenses
-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income (Loss)
1,230	1,146	830	785	769	748	1,089	1,054	1,043	1,089	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Income (Expense), Net
23	20	36	33	31	29	27	27	26	23	8	10	14	19	30	26	22	17	19	19	18	17	1	3	6	9	-0	0	0	-	0	0	-	-	-	0	-	2	-1	-1	0	0	0
Special (gains) charges, net (Note 4)
-	-	0	0	-	-7	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Nonoperating Income (Expense)
8	8	9	5	2	4	7	5	4	-1	-6	-5	-3	-4	-7	-6	-7	-4	-7	-9	-8	-7	-2	-0	0	-1	-2	-3	-2	-1	-1	-2	-1	4	5	10	11	8	7	6	0	0	0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest
1,253	1,166	849	796	775	761	1,087	1,050	1,004	1,034	911	884	848	737	704	670	643	622	588	558	1,229	1,144	1,111	1,090	397	511	530	523	493	388	337	301	284	283	285	293	287	268	292	288	0	0	0
Income Tax Expense (Benefit)
145	119	75	71	10	39	374	393	444	451	166	168	191	168	152	141	128	127	124	118	355	332	334	331	92	122	126	128	122	96	72	54	46	46	46	58	53	50	65	62	0	0	0
Net income
1,107	1,046	773	724	765	722	712	656	560	583	744	716	656	569	551	528	514	494	463	439	874	811	777	759	305	389	403	395	370	291	265	247	237	236	238	234	234	218	226	226	0	0	0
Earnings Per Share [Abstract]
Earnings Per Share, Basic
1.49	1.35	1.32	1.16	1.20	0.04	1.08	1.35	0.98	-0.01	0.81	0.88	1.09	0.74	0.66	0.60	0.67	0.66	0.55	0.52	0.57	-2.83	0.89	5.18	0.57	-1.04	0.69	0.83	1.26	0.78	0.60	0.59	0.57	0.55	0.45	0.51	0.56	0.57	0.42	0.51	0.42	0.65	0.42
Earnings Per Share, Diluted
1.47	1.31	1.30	1.14	1.18	0.04	1.06	1.32	0.96	-0.01	0.79	0.86	1.06	0.72	0.65	0.58	0.66	0.64	0.54	0.51	0.56	-2.78	0.87	5.09	0.56	-1.02	0.68	0.81	1.24	0.76	0.58	0.57	0.55	0.54	0.43	0.48	0.53	0.55	0.40	0.48	0.40	0.63	0.41
Weighted-average number of common shares outstanding:
Weighted Average Number of Shares Outstanding, Basic
208	209	208	208	207	208	209	209	210	210	211	210	211	213	213	212	213	216	215	215	215	533	106	105	106	556	111	112	113	115	115	114	114	114	114	114	114	114	113	113	113	112	112
Weighted Average Number of Shares Outstanding, Diluted
211	212	212	212	212	212	213	214	215	215	216	215	216	218	218	217	217	220	219	219	220	543	108	107	108	566	112	114	116	117	119	118	118	118	119	120	120	120	118	118	119	117	117